Search results for "Keeping tabs"
Spotlight on GLP-1 receptor agonists and suicidality
Several recent studies did not find an association between glucagon-like peptide-1 (GLP-1) receptor agonists and suicidality, but one analysis identified a potential risk in patients with mental health issues before starting semaglutide.
https://diabetes.acponline.org/archives/2024/09/13/5.htm
13 Sep 2024
Spotlight on glycemic variability
Recent research quantified the association between visit-to-visit variability in HbA1c levels and risk of cardiovascular disease and death.
https://diabetes.acponline.org/archives/2020/04/10/5.htm
10 Apr 2020
Spotlight on treatment of COVID-19 in diabetes patients
Experts addressed minimizing cardiovascular risk, managing diabetes in the ICU, altering protocols, and monitoring glucose levels, while studies looked at insulin infusion and other interventions for patients with COVID-19.
https://diabetes.acponline.org/archives/2020/06/12/6.htm
12 Jun 2020
Spotlight on young-onset type 2 diabetes
Some recent studies investigated cardiovascular disease, mortality risk, kidney disease, and the evidence base among patients who develop type 2 diabetes before age 40 or 50 years.
https://diabetes.acponline.org/archives/2020/07/10/5.htm
10 Jul 2020
Spotlight on glycemic control and patient age
Recent studies found higher HbA1c levels in younger patients with diabetes compared to older ones, as well as differences in medication therapy by age.
https://diabetes.acponline.org/archives/2020/03/13/5.htm
13 Mar 2020
Spotlight on COVID-19 and diabetes
Experts gave advice on which diabetes drugs should be stopped in patients with COVID-19, and studies highlighted associations between the two diseases.
https://diabetes.acponline.org/archives/2020/05/08/5.htm
8 May 2020
Spotlight on hypoglycemia
The risks and consequences of hypoglycemia were described by several studies published recently.
https://diabetes.acponline.org/archives/2013/08/09/9.htm
9 Aug 2013
Spotlight on SGLT-2 inhibitors and heart failure
The effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on heart failure, in patients with and without diabetes, were the focus of three analyses published in the past month, two on dapagliflozin and one on canagliflozin.
https://diabetes.acponline.org/archives/2019/10/11/5.htm
11 Oct 2019
Spotlight on temperature and light
Recent studies looked at light therapy for depression and diabetes, seasonal variation in glycemic control, and associations between outdoor sunlight and temperature and metabolism.
https://diabetes.acponline.org/archives/2019/03/08/5.htm
8 Mar 2019
Spotlight on diabetes prevention
Recent studies looked at vitamin D supplementation, peer mentoring, and physician referrals to diabetes prevention programs among patients with prediabetes.
https://diabetes.acponline.org/archives/2019/06/14/5.htm
14 Jun 2019